Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination.

There was a nonsignificant trend toward higher mortality in the aliskiren group, although total mortality (3%) is low compared with the other post-MI trials.

also in 5,406 other papers